جست‌وجوی استاد و پژوهشگر

Björn Burckhardtمشاهده پروفایل

استاد

• Individualized Pharmacotherapy
• Clinical Pharmacy
• Mass Spectrometry
• +۷ مورد دیگر

Prof. Dr. Björn Burckhardt serves as Professor at the Institute for Pharmaceutical and Medicinal Chemistry at the University of Münster, where he leads research in Clinical Pharmacy with a focus on Individualized Pharmacotherapy. His laboratory, located in Room 120.268 at Corrensstr. 48, Münster, conducts cutting-edge research on pathophysiologically relevant peptide cascades using mass spectrometry. Dr. Burckhardt's research primarily centers on the kallikrein-kinin system and its complex interplay with the renin-angiotensin-aldosterone system, complement system, and neurokinins. His work has significant implications for understanding and treating major diseases including hypertension, diabetes mellitus, cancer, hereditary angioedema, sepsis, and malaria. By developing reliable mass spectrometric techniques, his team aims to identify new drug targets and advance personalized medicine approaches through comprehensive pharmacokinetic, pharmacodynamic, and metabolomic analyses. His recent publications demonstrate a strong focus on antimalarial compounds, HDAC inhibitors for cancer therapy, and the role of peptide systems in inflammatory conditions including COVID-19. The research spans from analytical method development to clinical applications, with particular emphasis on pediatric pharmacology and translational medicine. Dr. Burckhardt has earned significant recognition including: Frey-Werle Prize (2022) for contributions to kallikrein-kinin system research Marie Skłodowska-Curie Global Fellowship (2022) He actively collaborates through consortia including LENA and CARS, with research that bridges analytical chemistry, pharmacology, and clinical medicine. His laboratory regularly recruits PhD students with backgrounds in pharmacy, chemistry, and related disciplines for research involving mass spectrometry and bioanalytical techniques. The research group comprises multiple scientists including Dr. Tanja Gangnus (who received the Walter Schunack Prize in 2023), several research assistants, and technical staff, working together to advance understanding of peptide cascades and their clinical applications.

• Pharmaceutical Science
• Toxicology
• 3D Printing
• +۴ مورد دیگر

Elke Prasad is a researcher affiliated with the Institute of Pharmacy and Biomedical Sciences at the University of Strathclyde, United Kingdom. Their work focuses on pharmaceutical sciences, particularly in areas such as 3D printing, drug delivery systems, and advanced dissolution assessment. Prasad has contributed to interdisciplinary collaborations, including projects on tablet micro-structure control and digital design for sustainable medicines development. Research interests include 3D printing applications in pharmaceuticals Drug release mechanisms Crystallization processes Polymers in drug formulation Prasad has co-authored publications in the International Journal of Pharmaceutics , emphasizing innovations in solid dosage forms and quality-by-design frameworks. They are part of a network of collaborators from institutions like University of Strathclyde, University of Manchester, and Imperial College London.

Bjarke Strøm Larsenمشاهده پروفایل

مدرس ارشد

• Pharmaceutics
• Drug Delivery Systems
• Polymer-based Drug Formulations
• +۴ مورد دیگر

Bjarke Strøm Larsen serves as a Senior Lecturer in the Department of Pharmacy at the University of Oslo, specifically within the Section for Pharmaceutics and Social Pharmacy (known as Section for Galenic Pharmacy and Community Pharmacy in English). His academic work focuses on advanced pharmaceutical formulation technologies with particular emphasis on drug delivery systems. His research interests span multiple cutting-edge areas of pharmaceutics including amorphous solid dispersions, 3D printed pharmaceuticals, personalized drug delivery systems, and polymer-based formulations. Larsen's work bridges fundamental pharmaceutical science with practical applications, particularly in enhancing drug solubility, permeation, and bioavailability. His research has significant implications for cancer drug delivery, pediatric formulations, and site-specific drug delivery approaches. Analysis of his recent publications (2022-2024) reveals a strong focus on innovative drug delivery technologies, with particular attention to amorphous solid dispersions, 3D printing of pharmaceuticals, and novel assessment methods for drug permeation. His work consistently addresses challenges in drug solubility, bioavailability enhancement, and personalized medicine approaches. The publications demonstrate interdisciplinary collaboration across pharmaceutical sciences, materials science, and analytical chemistry. Larsen is actively involved in two research groups at the University of Oslo: Personalized Dosage Form Design (PersDrug) Site-specific Drug Delivery (SiteDel) These affiliations highlight his research focus on tailoring drug delivery systems to individual patient needs and developing targeted delivery approaches. His work shows consistent productivity with multiple high-impact publications in leading pharmaceutical journals including European Journal of Pharmaceutics and Biopharmaceutics, Journal of Pharmaceutical Sciences, and International Journal of Pharmaceutics. While specific grant information isn't provided in the available text, his extensive collaborative work suggests significant research funding support.

• Oral Drug Absorption
• Biopharmaceutics
• Drug Dissolution
• +۵ مورد دیگر

James E. Polli is a Professor and Ralph F. Shangraw/Noxell Endowed Chair in Industrial Pharmacy and Pharmaceutics at the University of Maryland School of Pharmacy, where he holds a primary appointment in the Department of Pharmaceutical Sciences. He serves as co-Director of the FDA-funded University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) and the Center for Research on Complex Generics (CRCG), and directs the online MS in Regulatory Science program. His leadership spans regulatory science initiatives and complex generics research. Dr. Polli earned his PhD in Pharmaceutics from the University of Michigan and BS in Pharmacy from Philadelphia College of Pharmacy and Science. His research centers on oral drug absorption, with dual emphases on maximizing oral bioavailability through formulation/chemical approaches and developing public quality standards for oral dosage forms. He has pioneered methodologies in biopharmaceutics classification, dissolution testing, and bioequivalence assessment. His publication portfolio reveals a strong trend toward physiologically based biopharmaceutics modeling (PBBM), biowaiver monographs for complex drugs, and advanced dissolution-permeation systems. Recent work focuses on predicting food effects, surfactant-mediated dissolution, and quality standards for amorphous solid dispersions. His research bridges academic innovation with regulatory applications through FDA collaborations. Fellow of the American Association for Pharmaceutical Scientists (AAPS) American Pharmacists Association Takeru Higuchi Research Prize recipient 2024 American Association of Colleges of Pharmacy Volwiler Research Achievement Award 2022 AAPS Global Leadership Award 2021 TOPRA Education Award Dr. Polli has advised 25 PhD graduates and secured significant FDA funding for M-CERSI and CRCG. His grant portfolio emphasizes regulatory science infrastructure, complex generics development, and educational initiatives. He served 12 years as editor of Pharmaceutical Research and contributes to FDA workshops on bioequivalence standards. His laboratory work integrates dissolution-hollow fiber membrane systems, biorelevant media modeling, and quality-by-design approaches for complex drug products.

• Pediatrics
• Anesthesiology
• Pharmacology
• +۴ مورد دیگر

Lliana Potts is a Research Fellow at the UWA Medical School , affiliated with the Emergency Medicine department and the Institute for Paediatric Perioperative Excellence . Her work focuses on pediatric anesthesia safety and recovery outcomes. Research Interests: Her expertise spans Pediatrics , Anesthesiology , and Pharmacology , with emphasis on adverse event prevention, pain management, and drug formulation tolerability in children. She contributes to UN Sustainable Development Goals through clinical studies in pediatric care. Publication Trends (2019-2023): Her research includes Randomized controlled trials comparing intubation techniques Postoperative care plans for tonsillectomy recovery Analgesic formulations for dental procedures Allergy screening protocols in anesthesia Pharmacokinetic studies on tramadol delivery Scientific Awards: 2017: Received award for groundbreaking research on Salbutamol premedication reducing respiratory complications in pediatric tonsillectomy patients Grants & Collaborations: Currently collaborating on the Dormouse project (2025) under the Channel 7 Telethon Trust , with international partners in pediatric perioperative care.

• Pharmaceutical Technology
• Dermatological Applications
• Nanodispersions
• +۶ مورد دیگر

Prof. Rolf Daniels is a Professor in the Department of Pharmaceutical Technology at the University of Tübingen’s Faculty of Science, located at Auf der Morgenstelle 8, Tübingen. His research focuses on innovative drug delivery systems, including nanodispersions, electrospun fibers, and formulations derived from natural extracts. He specializes in dermatological applications, wound healing, and phytochemical characterization of medicinal plants like Matricaria recutita (chamomile) and Hypericum perforatum (St. John’s wort). His work spans supercritical fluid extraction, emulsion science, and the development of biomaterials for controlled drug release. Key contributions include studies on betulin-containing foams, probiotic orodispersible tablets, and the use of alkyl polyglucosides in topical formulations. He has also explored the impact of fermentation on plant extracts and the optimization of oral drug delivery systems for pediatric use. Prof. Daniels’ publications emphasize interdisciplinary approaches, combining analytical chemistry, material science, and pharmacology. His recent work (2023–2025) highlights advancements in phase-reversal foams, electrospun wound dressings, and co-amorphous drug formulations. While no specific awards are listed, his extensive publication record reflects sustained contributions to pharmaceutical technology. His research also includes collaborations on formulation stability, skin permeation studies using confocal Raman microscopy, and the development of thixotropic silicone oils for medical applications. Ongoing projects involve supercritical fluid technology for 3D-printed drug delivery systems and the evaluation of natural preservatives in semisolid dosage forms.

Alice Chuahمشاهده پروفایل

دانشیار

• Drug Delivery Systems
• Nanomedicine
• Cancer Treatment
• +۴ مورد دیگر

Dr. Alice Chuah is an Associate Professor at the School of Pharmacy, Monash University Malaysia. She specializes in pharmaceutical sciences with a focus on advanced drug delivery systems. Her work integrates nanotechnology, materials science, and pharmaceutics to improve drug efficacy while minimizing side effects. She leads the Wound and Dermal Delivery Focus Group in Malaysia's Controlled Release Society. Dr. Chuah holds a PhD in Pharmacy from Universiti Nottingham Malaysia and a Master of Pharmacy from the University of Strathclyde. Education: Graduate Certificate in Higher Education (GCHE), Monash University Malaysia Doctor of Philosophy in Pharmacy, Universiti Nottingham Malaysia Master of Pharmacy, University of Strathclyde Her research emphasizes nanoparticle systems, hydrogels, and polymeric membranes for drug delivery, addressing challenges like poor drug solubility and non-specific distribution. She has expanded into sustainable water filtration membranes for underserved rural areas. Notable recognitions include the APEC–Australia Women in Research Fellowship and the MAKNA Cancer Research Award. Dr. Chuah actively supervises PhD students and leads multiple research projects focused on chemoresistance mechanisms, QSAR-guided drug design, and clinical trials for wound healing products. Recent projects include developing tocotrienol-based wound dressings and investigating tumor gene interactions in breast cancer. Collaborations span Malaysia and international institutions. Her publications (52+ articles) emphasize drug delivery innovations and nanomedicine applications. She promotes public engagement through initiatives like the ASEAN Sustainable Development Grant Scheme and media features on drug formulation advancements.

Clémence Fauteux-Lefebvreمشاهده پروفایل

استادیار

• Versatile catalysts
• Multi-phase reaction characterization
• Multifunctional materials
• +۱ مورد دیگر

Clémence Fauteux-Lefebvre is an Assistant Professor in the Department of Chemical and Biological Engineering at the University of Ottawa's Faculty of Engineering. She holds a PhD (2015), MASc (Sherbrooke), and BASc (Ottawa) in Chemical Engineering. Her research focuses on sustainable catalysis, versatile catalyst design, and multifunctional materials to enhance process efficiency and reduce environmental impact. Previously, she conducted postdoctoral work on process analytical technologies at Pfizer. Educations: PhD in Chemical Engineering, Université de Sherbrooke (2015) MASc in Chemical Engineering, Université de Sherbrooke BASc in Chemical Engineering, University of Ottawa Research Interests: Prof. Fauteux-Lefebvre specializes in developing adaptive catalysts for multi-stage reactions and sustainable processes. Her work integrates materials science, environmental engineering, and AI-driven optimization to address challenges in sulfur oxide capture, catalytic conversion, and process intensification. Key areas include: Multi-phase reaction systems Graphene-based nanomaterials Machine learning for process modeling Publications Trends: Her recent articles emphasize catalyst design (e.g., graphene-iron oxide composites), sulfur conversion processes, and AI applications in chemical engineering. She also explores environmental remediation through novel adsorbent materials and sustainable material synthesis. Awards: No scientific awards explicitly mentioned in the provided texts. Advising/Grants: Advising information and grants are not detailed in the current data. She may supervise students through her research projects on catalysis and materials science. Labs/Teams: Engaged with the Department's chemical engineering research groups, focusing on sustainable processes and advanced materials characterization.

• Gene Therapeutics
• Protein Therapeutics
• Monoclonal Antibody Formulation
• +۸ مورد دیگر

Amal Ali Elkordy is a Professor of Pharmaceutics at the University of Sunderland, where she has held roles from Lecturer (promoted to Senior Lecturer in 2009, Reader in 2013, and Professor in 2019). She is also an External Examiner for multiple programs at the University of Portsmouth, University of Bradford, and Kingston University. Her educational background includes a Pharmacy degree and MPhil from the University of Tanta, Egypt, followed by a PhD in Pharmaceutical Technology from the University of Bradford's School of Pharmacy. Education: BPharm, University of Tanta, Egypt MPhil in Pharmaceutical Technology, University of Tanta, Egypt PhD in Pharmaceutical Technology, School of Pharmacy, University of Bradford, UK Her research focuses on formulation, stabilization, and delivery of peptide/protein drugs, including monoclonal antibodies, using advanced technologies like spray drying and microfluidics. She explores dissolution enhancement of hydrophobic drugs via liquisolid systems, liposomes, and polymeric micelles, as well as targeted drug release strategies (e.g., floating tablets) and nanomedicines for cancer, Alzheimer’s, Parkinson’s, and viral infections. Her work bridges lab research to clinical applications, emphasizing non-invasive routes for monoclonal antibody therapies. Elkordy has authored over 150 publications and co-edited a textbook on monoclonal antibody formulations. Her articles emphasize innovative drug delivery systems, including 3D-printed polypills and nanoformulations for antibiotics like vancomycin. She actively chairs conference sessions and reviews for journals like Pharmaceutics and publishers like Elsevier. Her research collaborations span academia and industry, notably as a reviewer for MHRA and guest editor for MDPI’s special issue on antibody-drug conjugates. She has supervised numerous PhD students to completion, with current advisees focusing on cannabinoid anti-inflammatory therapies, 3D-printed fast-disintegrating formulations, and peptide niosome spray drying. Her students have received awards such as the Thermal Methods Group bursary (2015) and commendations from GlaxoSmithKline and the British Pharmaceutical Students’ Association. Grants and funding include overseas government support and industry partnerships through the EPSRC/EHDA network. Elkordy’s expertise in formulation science has driven her to lead the MSc Pharmaceutical and BioPharmaceutical Formulations program at Sunderland, integrating her research on biopharmaceuticals and nanomedicines. She collaborates in labs focused on lipid-based drug delivery, gene therapies, and protein stabilization, contributing to over 20 academic and industrial partnerships in the UK’s pharmaceutical sector.

Else Holmfredمشاهده پروفایل

استاد مهمان

• Analytical Chemistry
• Pharmaceutical Science
• Isotope Analysis
• +۳ مورد دیگر

Else Holmfred is a Visiting Professor at Stanford University's Department of Earth & Planetary Sciences, where she integrates advanced analytical chemistry, biogeochemistry, and pharmaceutical science to develop innovative methodologies for detecting non-visual drug counterfeits. Her research leverages isotopic analysis (IRMS/MC-ICPMS) and trace elemental analysis (ICP-MS) to address critical challenges in pharmaceutical integrity. Stanford University, Department of Earth & Planetary Sciences Her work focuses on applying geochemical tools to pharmaceutical problems, earning recognition through competitive fellowships. She has pioneered techniques for isotopic fingerprinting and trace element profiling to authenticate drug products, bridging planetary science with medical quality assurance. Key trends in her publications include: Isotopic and elemental analysis for drug authentication Nanoparticle dissolution behavior in biological contexts AI-driven quality control for pharmaceutical manufacturing Case-based pedagogy in analytical chemistry education Honors include: Novo Nordisk Foundation Visiting Scholar Stanford Bio-X Fellowship (2023) Carlsberg Foundation Internationalisation Fellowship (2022) Contact: holmfred@stanford.edu

Ahmed Faheemمشاهده پروفایل

مدرس ارشد

• Pharmaceutical Nanotechnology
• Drug Delivery and Targeting
• Controlled Release Systems
• +۴ مورد دیگر

Ahmed Faheem is a Senior Lecturer in Pharmaceutics at the School of Pharmacy and Pharmaceutical Sciences, University of Sunderland. He holds a PhD in Drug Delivery and Targeting from UCL School of Pharmacy (2006) and conducted postdoctoral research at Strathclyde Institute of Pharmacy and Biomedical Sciences (pulmonary anticancer delivery) and Queen’s University Belfast (HIV microbicides). He co-founded Ulster University's School of Pharmacy and Pharmaceutical Sciences, serving as MSc Course Director (2010-2015). Research Focus: Pharmaceutical nanotechnology for targeted delivery of biotherapeutics Key Areas: Biodegradable nanoparticles, 3D tablet printing, pulmonary delivery Collaborations: Bradford Institute for Cancer Therapeutics (patent holder) His teaching portfolio includes dosage form design, biopharmaceutics, and controlled release systems. He supervises 12 PhD/MSc students on topics spanning glioblastoma targeting, metastatic cancer strategies, and wound healing applications. As a journal associate editor and reviewer for leading pharmaceutics publications, he contributes to field advancements.

Paul Anthony Carterمشاهده پروفایل

مدرس ارشد

• Pharmaceutics
• Drug Delivery
• Solid Dosage Forms
• +۲ مورد دیگر

Paul Anthony Carter is a Senior Lecturer and practising Community Pharmacist at the University of Sunderland, affiliated with the Department of Pharmaceutical Sciences. He teaches modules such as PHA111 (MPharm) and DDDM14 (Drug Discovery and Development). Research Interests: His work spans pharmaceutics , with a focus on powder technology , solid dosage forms , and drug delivery systems . His PhD explored electrostatic charging in powder mixing for inhaled therapies, and he has supervised two PhD students in related areas. Publication Trends: His research trajectory includes studies on floating tablet formulations , flowability issues in liquisolid compacts , and electrostatic properties of pharmaceutical powders , alongside clinical studies on medication adherence in mental health. Email: paul.carter@sunderland.ac.uk Location: Sciences Complex, University of Sunderland

• Pharmaceutical Formulation
• Drug Delivery Systems
• Nanoparticle Technology
• +۳ مورد دیگر

Ecevit Bilgili is a Professor in the Department of Chemical and Materials Engineering at New Jersey Institute of Technology (NJIT). His research focuses on pharmaceutical formulation engineering, particularly in nanoparticle technology, drug delivery systems, and process modeling for pharmaceutical nanomaterials. He has been involved in federal grants, including the National Science Foundation-funded Center for Integrated Material Science and Engineering of Pharmaceutical Products (CIMSEPP), where he serves as a Co-Principal Investigator. His work emphasizes nanomilling processes, population balance modeling, and drug solubility enhancement. Key research areas include analyzing bead material effects, thermal dynamics in milling, and developing semi-mechanistic models for nanosuspension production. Media coverage highlights innovations like 3D printing of drug-loaded tablets and advances in formulation modeling. Bilgili has an h-index of 35 with 3,827 citations, reflecting his significant contributions to pharmaceutical engineering. His interdisciplinary collaborations span material science, chemical engineering, and biotechnology, addressing challenges in scalable pharmaceutical manufacturing and personalized drug delivery systems.

Kofi Asare-Addoمشاهده پروفایل

استاد

• Pharmaceutics
• Drug Delivery Systems
• UV Imaging
• +۴ مورد دیگر

Kofi Asare-Addo is a Reader in Pharmaceutics at the University of Huddersfield's School of Applied Sciences. He is a member of the Pharmaceutics and Drug Delivery Centre and an associate member of the Biopolymer Research Centre. He holds a PhD from the Medway School of Pharmacy, University of Kent (2012), completed through an Industrial CASE studentship with Colorcon. His research focuses on UV imaging, complexations, solubility enhancements, and drug delivery systems, with contributions to UN Sustainable Development Goals related to health and innovation. Education: PhD in Pharmaceutics (Medway School of Pharmacy, University of Kent, 2012). Industrial CASE studentship with Colorcon. Postdoctoral roles at the University of Huddersfield included Research Assistant, Research Fellow, and Senior Lecturer before his current position. He became a Fellow of the Higher Education Academy in 2014. Research Interests: UV dissolution imaging, hydrogel matrices, nanoparticle drug delivery systems, and advanced pharmaceutical formulations. His work spans nanotechnology, 3D printing in drug delivery, and biopolymer applications. Recent studies emphasize smart hydrogels, nasal drug delivery, and multi-responsive in-situ systems. Scientific Awards: Fellow of the Higher Education Academy (2014). Advising and Grants: Supervised 10 PhD projects and served as an external examiner at universities like Sheffield Hallam and Durham. Collaborates with pharmaceutical industries and global academic institutions. Active in editorial roles and professional networks like the Academy of Pharmaceutical Sciences. Labs/Teams: Leads projects within the Pharmaceutics and Drug Delivery Centre, focusing on novel drug delivery technologies. Engages in cross-disciplinary collaborations, particularly in biomaterials and biomedical engineering.

Valentyn Mohylyukمشاهده پروفایل

پژوهشگر

• Pharmaceutical Technology
• Drug Delivery Systems
• Formulation Science
• +۴ مورد دیگر

Dr. Valentyn Mohylyuk is a pharmaceutical scientist serving as Lead Researcher and Scientific Project Manager at Riga Stradiņš University's pharmaceutical scientific group. He holds a BS/MS in Pharmaceutical Technology and a PhD in Pharmaceutical Science. His career spans academic and industrial roles, including positions at Freie Universität Berlin, University of Hertfordshire, and Queen's University Belfast. His research focuses on formulation science, drug delivery systems, and advanced manufacturing techniques like 3D printing and hot-melt extrusion. Key interests include enhancing drug solubility/bioavailability, developing abuse-deterrent formulations, and continuous manufacturing processes. Education: PhD in Pharmaceutical Science (Year unspecified) BS/MS in Pharmaceutical Technology (Year unspecified) Research Interests: Oral dosage form development with tailored drug release profiles Amorphous solid dispersions and polymer-based formulations 3D printing (FDM) for personalized dosage forms Continuous manufacturing via extrusion and roll compaction Biopharmaceutical permeability studies Articles Trends: Recent work emphasizes 3D printing applications, polymer-drug interactions in amorphous systems, and melt granulation optimization. Key themes include overcoming solubility challenges and advancing manufacturing technologies. Scientific Awards: Letter of Appreciation from the President of the Latvian Academy of Sciences (2024) Grants/Advising: Active projects include sugar alcohol binders in melt granulation (EU-funded) and amorphization mechanisms (Latvian Council) Advising on student projects like solvent effects in solid dispersions Labs/Teams: Leads Riga Stradiņš University's pharmaceutical research group, collaborating internationally on formulation science and advanced manufacturing.